Genenta Science S.p.A. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
Genenta Science S.p.A. (GNTA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of EUR 937.74 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2026-04-01
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|---|
| 2025-12-31 | 937.74K EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | 352.36K EUR 6-K · filed 2025-10-10 | |
| 2024-12-31 | 847.25K EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | 232.77K EUR 6-K · filed 2025-10-10 | |
| 2023-12-31 | 324.45K EUR 6-K · filed 2024-10-29 | 739.88K EUR 20-F · filed 2026-04-01 |
| 2023-06-30 | 415.43K EUR 6-K · filed 2024-10-29 | |
| 2022-12-31 | 722.74K EUR 20-F · filed 2025-03-28 | |
| 2022-06-30 | 240.04K EUR 6-K · filed 2023-10-20 | |
| 2021-12-31 | 497.10K EUR 20-F · filed 2024-03-29 | |
| 2021-06-30 | 497.10K EUR 6-K · filed 2022-10-25 | |
| 2020-12-31 | 460.19K EUR 20-F · filed 2023-04-21 | |
| 2019-12-31 | 740.81K EUR 20-F · filed 2022-05-02 |